Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
Adkins, Douglas, Prof, Ley, Jessica, BS, Neupane, Prakash, MD, Worden, Francis, Prof, Sacco, Assuntina G, MD, Palka, Kevin, MD, Grilley-Olson, Juneko E, MD, Maggiore, Ronald, MD, Salama, Noha N, PhD, Trinkaus, Kathryn, PhD, Van Tine, Brian A, MD, Steuer, Conor E, MD, Saba, Nabil F, Prof, Oppelt, Peter, MD
Published in The lancet oncology (01.09.2019)
Published in The lancet oncology (01.09.2019)
Get full text
Journal Article
Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial
Oppelt, Peter, Ley, Jessica C., Worden, Francis, Palka, Kevin, Maggiore, Ronald, Liu, Jingxia, Adkins, Douglas
Published in Oral oncology (01.03.2021)
Published in Oral oncology (01.03.2021)
Get full text
Journal Article
Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma
Lee, David S, Mahal, Rajwant S, Tharakan, Theresa, Cathryn Collopy, Kallogjeri, Dorina, Thorstad, Wade L, Adkins, Douglas R, Oppelt, Peter, Ley, Jessica, Wick, Cameron C, Zevallos, Jose
Published in Otolaryngology-head and neck surgery (01.05.2023)
Published in Otolaryngology-head and neck surgery (01.05.2023)
Get more information
Journal Article
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response
Schillebeeckx, Ian, Earls, Jon, Flanagan, Kevin C, Hiken, Jeffrey, Bode, Alex, Armstrong, Jon R, Messina, David N, Adkins, Douglas, Ley, Jessica, Alborelli, Ilaria, Jermann, Philip, Glasscock, Jarret I
Published in Scientific reports (25.01.2022)
Published in Scientific reports (25.01.2022)
Get full text
Journal Article
358 Ramucirumab in combination with pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous-cell carcinoma: a phase 1–2 trial
Adkins, Douglas, Ley, Jessica, Palka, Kevin, Jacobs, Miriam, Liu, Jingxia, Oppelt, Peter
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
nab -Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma
Adkins, Douglas, MD, Ley, Jessica, BS, Michel, Loren, MD, Wildes, Tanya M., MD, MSCI, Thorstad, Wade, MD, Gay, Hiram A., MD, Daly, Mackenzie, MD, Rich, Jason, MD, Paniello, Randal, MD, Uppaluri, Ravindra, MD, Jackson, Ryan, MD, Trinkaus, Kathryn, PhD, Nussenbaum, Brian, MD
Published in Oral oncology (01.10.2016)
Published in Oral oncology (01.10.2016)
Get full text
Journal Article
Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma
Chatzkel, Jonathan, Lewis, James S., Ley, Jessica C., Wildes, Tanya M., Thorstad, Wade, Gay, Hiram, Daly, Mackenzie, Jackson, Ryan, Rich, Jason, Paniello, Randal, Nussenbaum, Brian, Liu, Jingxia, Siegel, Barry A., Dehdashti, Farrokh, Adkins, Douglas
Published in Head & neck pathology (Totowa, N.J.) (01.09.2017)
Published in Head & neck pathology (Totowa, N.J.) (01.09.2017)
Get full text
Journal Article
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma
Van Tine, Brian A, Weiss, Mia C, Hirbe, Angela C, Oppelt, Peter J, Abaricia, Sarah, Trinkaus, Kathryn, Luo, Jingqin, Berry, Shellie, Ruff, Tyler, Callahan, Cheryl, Toensikoetter, Jacqui, Ley, Jessica, Siegel, Marilyn J, Dehdashti, Farrokh, Siegel, Barry A, Adkins, Douglas R
Published in Rare tumors (2021)
Published in Rare tumors (2021)
Get full text
Journal Article
Palbociclib + cetuximab versus cetuximab in patients with CDKN2A -altered, anti-PD-1 resistant, HPV-negative head and neck squamous cell carcinoma (HNSCC): A phase 3 trial
Ley, Jessica C., Cohen, Jared, Liu, Jingxia, Thomeczek, Brianne, Oppelt, Peter John, Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Nanoparticle albumin-bound (nab) paclitaxel in combination with nivolumab as treatment of recurrent or metastatic head and neck squamous-cell carcinoma (RM-HNSCC) that progressed on a PD-1 inhibitor: A single-arm, phase 2 trial
Cohen, Jared, Oppelt, Peter John, Pennock, Sarah, Liu, Jingxia, Ley, Jessica C., Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with pembrolizumab and carboplatin as first-line treatment of recurrent or metastatic head and neck squamous-cell carcinoma (RM-HNSCC): A single-arm, phase 2 trial
Cohen, Jared, Ley, Jessica C., Liu, Jingxia, Haselhorst, Emma, Oppelt, Peter John, Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Tazemetostat, a selective EZH2 inhibitor, with pembrolizumab as treatment of anti-PD-1 resistant head and neck squamous-cell carcinoma (HNSCC): A phase 1-2 trial
Puram, Sidharth, Oppelt, Peter John, Ley, Jessica C., Cohen, Jared, Alberti, Justin, Shannon, Erik, Liu, Jingxia, Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Uppaluri, Ravindra, Campbell, Katie M, Egloff, Ann Marie, Zolkind, Paul, Skidmore, Zachary L, Nussenbaum, Brian, Paniello, Randal C, Rich, Jason T, Jackson, Ryan, Pipkorn, Patrik, Michel, Loren S, Ley, Jessica, Oppelt, Peter, Dunn, Gavin P, Barnell, Erica K, Spies, Nicholas C, Lin, Tianxiang, Li, Tiantian, Mulder, David T, Hanna, Youstina, Cirlan, Iulia, Pugh, Trevor J, Mudianto, Tenny, Riley, Rachel, Zhou, Liye, Jo, Vickie Y, Stachler, Matthew D, Hanna, Glenn J, Kass, Jason, Haddad, Robert, Schoenfeld, Jonathan D, Gjini, Evisa, Lako, Ana, Thorstad, Wade, Gay, Hiram A, Daly, Mackenzie, Rodig, Scott J, Hagemann, Ian S, Kallogjeri, Dorina, Piccirillo, Jay F, Chernock, Rebecca D, Griffith, Malachi, Griffith, Obi L, Adkins, Douglas R
Published in Clinical cancer research (01.10.2020)
Published in Clinical cancer research (01.10.2020)
Get full text
Journal Article
Oral NRC-2694-A in combination with paclitaxel as therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) that progressed on or after an immune checkpoint inhibitor (ICI): A multi-center, single-arm, phase 2 trial
Adkins, Douglas, Oppelt, Peter John, Ley, Jessica C., Myneni, Praveen Chowdary, Gogula, Venkata Ramana, Kanumuri, Satish, Yadla, Sheshubabu, Sadu, Venkata, Kota, Raghava, Sanagala, Saipavan, Surapaneni, Mounika
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Correlation of CDKN2A genomic alterations with tumor response to palbociclib given before chemoradiation therapy (CRT) to patients with human papillomavirus (HPV)-negative, locally advanced head and neck squamous-cell carcinoma (LA-HNSCC): A single-arm, phase 2 trial
Oppelt, Peter John, Ley, Jessica C., Paniello, Randal C, Puram, Sidharth, Jackson, Ryan, Pipkorn, Patrik, Rich, Jason, Gay, Hiram Alberto, Liu, Jingxia, Cohen, Jared, Thorstad, Wade, Adkins, Douglas
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial
Adkins, Douglas, Ley, Jessica, Atiq, Omar, Powell, Steven, Spanos, William C., Gitau, Mark, Rigden, Caron, Palka, Kevin, Liu, Jingxia, Oppelt, Peter
Published in Oral oncology (01.04.2021)
Published in Oral oncology (01.04.2021)
Get full text
Journal Article
Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Michel, Loren, Ley, Jessica, Wildes, Tanya M, Schaffer, András, Robinson, Anthony, Chun, Se-Eun, Lee, Wooin, Lewis, James, Trinkaus, Kathryn, Adkins, Douglas
Published in Oral oncology (01.07.2016)
Published in Oral oncology (01.07.2016)
Get full text
Journal Article
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial
Adkins, Douglas R., Lin, Jin-Ching, Sacco, Assuntina, Ley, Jessica, Oppelt, Peter, Vanchenko, Vyacheslay, Komashko, Nataliia, Yen, Chia-Jui, Wise-Draper, Trisha, Lopez-Picazo Gonzalez, Jose, Radulovic, Sinisa, Shen, Qi, Thurm, Holger, Martini, Jean-François, Hoffman, Justin, Huang, Xin, Melichar, Bohuslav, Tahara, Makoto
Published in Oral oncology (01.04.2021)
Published in Oral oncology (01.04.2021)
Get full text
Journal Article